Carter Todd Alfred

Carter Todd Alfred is listed in filings as Chief Scientific Officer at Voyager Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 26, 2026, including sale activity. Recent filings connect the profile to Voyager Therapeutics, Inc. (VYGR). The current snapshot covers public activity from Jan 15, 2025 to Feb 26, 2026. Reported amounts are shown as $15.7K to $13.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.